Masahiko Ando

机构：Nagoya University Hospital, Higashi Nagoya National Hospital, Nagoya University · ORCID：0000-0003-2891-5424

发表论文 669 篇 · 总被引 15756 次 · h-index 63

代表论文

• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure (2025 · Journal of Cardiac Failure · 被引 43)
• Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 18)
• Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018) (2024 · Journal of Clinical Oncology · 被引 17)
• Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial) (2024 · Stem Cells Translational Medicine · 被引 16)
• CORRIGENDUM: JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure (2025 · Circulation Journal · 被引 10)
• A randomized controlled trial comparing romosozumab and denosumab in elderly women with primary osteoporosis and knee osteoarthritis (2025 · Scientific Reports · 被引 6)